PLIANT THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.06 USD | +2.16% |
|
-3.41% | -32.80% |
Chart calendar Pliant Therapeutics, Inc.
f706.Yx6jODhn04em4PcTpfZMdOq9naDAoAHkbUtEm3lhdf8.LXHxdnElgKqVjYBf7aweB5v69uaLwnOPOi0hrA1MO5gzfeYKdVO10smqhA~7c8e64b9a2519982dd7e5c4b2d32aead
Upcoming events on Pliant Therapeutics, Inc.
Past events on Pliant Therapeutics, Inc.
| 16/04/2024 | Piper Sandler Spring Biopharma Symposium |
| 09/04/2024 16:45 | Needham Healthcare Conference |
| 12/03/2024 20:20 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 17:50 | TD Cowen Health Care Conference |
| 27/02/2024 | Wells Fargo West Coast Biotech Tour |
| 27/02/2024 21:03 | Q4 2023 Earnings Release |
| 13/02/2024 17:00 | Oppenheimer Healthcare Life Sciences Conference |
| 05/02/2024 13:00 | INTEGRIS-PSC Phase 2a Trial Results Call |
| 09/01/2024 15:30 | JPMorgan Healthcare Conference |
| 30/11/2023 14:00 | Piper Sandler Healthcare Conference |
| 28/11/2023 | Evercore ISI HealthCONx Conference |
| 15/11/2023 18:15 | Stifel Healthcare Conference |
| 13/11/2023 22:00 | American Association for the Study of Liver Diseases Conference - Abstract #5008 |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 04/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Abstract No 464 |
| 04/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Abstract No: 714 |
| 03/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Abstract No: 1467 |
| 28/09/2023 16:30 | Cantor Global Healthcare Conference |
| 26/09/2023 13:00 | INTEGRIS PSC Phase 2a Trial Results Call |
| 12/09/2023 | Baird Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 41,8 39,4 6.04% | 7,57 7,72 -1.96% | 9,69 8,99 7.71% | 1,58 2,45 -35.43% | 1,54 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -125 -123 -2.28% | -182 -186 2.23% | -218 |
|
EBIT Million USD | Released Forecast Spread | -41,6 -49,3 15.58% | -20,0 -101 80.12% | -127 -124 -2.92% | -184 -187 1.39% | -210 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,5 -61,0 31.91% | -19,7 -101 80.41% | -123 -122 -1.3% | -161 -170 5.34% | -203 |
|
Net income Million USD | Released Forecast Spread | -41,5 -61,0 31.91% | -19,7 -101 80.41% | -123 -122 -1.25% | -161 -170 5.06% | -201 |
|
EPS USD | Released Forecast Spread | -1,95 -2,90 32.76% | -2,71 -2,80 3.33% | -2,94 -2,89 -1.79% | -2,75 -2,91 5.34% | -3,29 |
| Announcement Date | 16/03/21 | 28/02/22 | 09/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,00 2,14 -6.71% | 1,25 1,05 18.95% | 4,99 1,20 315.79% | 1,48 1,59 -6.98% | 1,97 1,17 68.12% | 1,33 0,88 50.82% | 0,25 0,90 -72.36% | 0,00 0,63 - | 0,00 0,46 - | 0,39 | 0,39 | 0,39 | 0,64 | 0,50 |
|
EBITDA Million USD | Released Forecast Spread | -50,0 | -53,0 | -58,0 | -63,0 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -24,6 -27,6 10.89% | -28,2 -27,6 -2.33% | -29,6 -29,5 -0.61% | -31,9 -33,7 5.19% | -37,4 -33,5 -11.52% | -42,1 -37,3 -12.79% | -47,3 -42,5 -11.38% | -47,7 -48,3 1.29% | -47,0 -50,1 6.14% | -49,1 | -51,5 | -53,9 | -56,0 | -61,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,5 -27,9 12.04% | -28,1 -27,6 -1.95% | -29,5 -29,6 0.16% | -30,6 -34,2 10.42% | -35,1 -33,5 -4.68% | -37,5 -36,7 -2.3% | -41,2 -41,1 -0.12% | -41,5 -47,6 12.86% | -41,1 -50,9 19.26% | -46,7 | -49,7 | -52,5 | -54,9 | -59,1 |
|
Net income Million USD | Released Forecast Spread | -24,5 -27,9 12.01% | -28,1 -27,6 -1.9% | -29,5 -29,4 -0.5% | -30,6 -34,0 9.95% | -35,1 -33,5 -4.62% | -37,5 -36,9 -1.8% | -41,2 -41,3 0.32% | -41,5 -47,1 11.91% | -41,1 -50,2 18.17% | -46,5 | -49,2 | -51,8 | -53,6 | -59,1 |
|
EPS USD | Released Forecast Spread | -0,68 -0,77 11.69% | -0,78 -0,75 -3.54% | -0,82 -0,81 -1.08% | -0,65 -0,74 12.16% | -0,72 -0,70 -3.17% | -0,67 -0,67 0% | -0,70 -0,71 1.73% | -0,70 -0,78 10.67% | -0,69 -0,82 16.11% | -0,77 | -0,81 | -0,85 | -0,88 | -0,85 |
| Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 08/11/22 | 09/03/23 | 09/05/23 | 09/08/23 | 09/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Pliant Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PLRX Stock
- Calendar Pliant Therapeutics, Inc.
